DETECTION OF ANTIBODIES BLOCKING THYROTROPIN EFFECT USING CHINESE-HAMSTER OVARY CELLS TRANSFECTED WITH THE CLONED HUMAN TSH RECEPTOR

被引:33
作者
CHIOVATO, L [1 ]
VITTI, P [1 ]
BENDINELLI, G [1 ]
SANTINI, F [1 ]
FIORE, E [1 ]
CAPACCIOLI, A [1 ]
TONACCHERA, M [1 ]
MAMMOLI, C [1 ]
LUDGATE, M [1 ]
PINCHERA, A [1 ]
机构
[1] FREE UNIV BRUSSELS,FAC MED,INST RECH INTERDISCIPLINAIRE,BRUSSELS,BELGIUM
关键词
TSH BLOCKING ANTIBODY; CHO-R CELLS; FRTL-5; CELLS; TSH RECEPTOR ANTIBODY; AUTOIMMUNE THYROIDITIS; HYPOTHYROIDISM;
D O I
10.1007/BF03347782
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chinese hamster ovary (CHO) cells transfected with the cloned human TSH receptor (CHO-R) were used to develop an assay to detect thyroid autoantibodies blocking the TSH-dependent cAMP production (TSHBAb). The study group included 38 patients with goitrous Hashimoto's thyroiditis (HT) and 47 subjects with atrophic thyroiditis (AT). In the HT group, 8 patients had subclinical hypothyroidism (HT-SH) and 30 had overt hypothyroidism (HT-H). Thirty normal subjects served as controls. Immunoglobulin G (IgG) was prepared from serum by double chromatography on DEAE-Sephadex. CHO-R cells were seeded in 96-well plates and were cultured for 48 h before the assay in RPMI-1640 medium plus 1 mmol/L glutamine, 10% fetal calf serum, and 0.4 g/L geneticin. In the assay for TSHBAb, CHO-R cells were incubated with IgG alone (0.5-2 mg/ml), TSH alone (0.2-625 mU/L), or IgG plus TSH; all samples were diluted in hypotonic medium containing 0.5 mmol/L isobutylmethylxanthine (IBMX). After 2 h of incubation at 37 degrees C in 5% CO2 -95% air atmosphere, TSH-stimulation was quantified by measuring extracellular cAMP by a RIA. IgGs from normal subjects did not significantly modify the stimulation of adenylate cyclase produced by ISH, the results obtained ranging between -30% and +18% (mean+/-SD=-3+/-14%). All IgGs producing an inhibition greater than 2SD from the mean of controls (>25%) were considered positive for blocking antibodies. TSHBAb were detected in 1/8 (12.5%) patients with HT-SH, in 7/30 (23.3%) with HT-H and in 16/47 (34.0%) patients with AT. When the same IgGs were tested in FRTL-5 cells, TSHBAb were detected in 1/8 (12.5%) patients with HT-SH, in 5/30 (16.6%) with HT-H and in 15/47 (31.9%) with AT. TSHBAb results in CHO-R cells showed a good correlation with those in FRTL-5 cells (r=0.74, p<0.0001), but 3/24 IgGs were positive for TSHBAb in CHO-R cells and negative in FRTL-5 cells. Using the radioreceptor assay, TSH-binding inhibiting antibodies were detected in 17/24 (70.8%) sera that contained TSHBAb when tested in the CHO-R cell system. Thyroid stimulating antibody (TSAb) and TSHBAb, that coexisted in 5 IgGs, were simultaneously detected using CHO-R cells. These IgGs belonged to patients in whom spontaneous hypothyroidism developed after hyperthyroidism, or viceversa. In conclusion a new in vitro assay for the detection of TSHBAb was developed using CHO-R cells. The sensitivity of this assay is slightly greater than that obtained in FRTL-5 cells and definitely greater than that of the radioreceptor assay. CHO-R cells have the advantages of expressing the human TSH receptor and of requiring less cumbersome procedures for cell culture than FRTL-5 cells.
引用
收藏
页码:809 / 816
页数:8
相关论文
共 37 条
  • [1] BLOCKING TYPE ANTITHYROTROPIN RECEPTOR ANTIBODY IN PATIENTS WITH NONGOITROUS HYPOTHYROIDISM - ITS INCIDENCE AND CHARACTERISTICS OF ACTION
    ARIKAWA, K
    ICHIKAWA, Y
    YOSHIDA, T
    SHINOZAWA, T
    HOMMA, M
    MOMOTANI, N
    ITO, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (05) : 953 - 959
  • [2] INCIDENCE OF ANTIBODIES BLOCKING THYROTROPIN EFFECT INVITRO IN PATIENTS WITH EUTHYROID OR HYPOTHYROID AUTOIMMUNE-THYROIDITIS
    CHIOVATO, L
    VITTI, P
    SANTINI, F
    LOPEZ, G
    MAMMOLI, C
    BASSI, P
    GIUSTI, L
    TONACCHERA, M
    FENZI, G
    PINCHERA, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (01) : 40 - 45
  • [3] DETECTION AND CHARACTERIZATION OF AUTOANTIBODIES BLOCKING THE TSH-DEPENDENT CAMP PRODUCTION USING FRTL-5 CELLS
    CHIOVATO, L
    VITTI, P
    LOMBARDI, A
    LOPEZ, G
    SANTINI, F
    MACCHIA, E
    FENZI, GF
    MAMMOLI, C
    BATTIATO, S
    PINCHERA, A
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (04) : 383 - 388
  • [4] INHIBITION OF THYROTROPIN-STIMULATED ADENYLATE-CYCLASE ACTIVATION AND GROWTH OF RAT-THYROID CELLS, FRTL-5, BY IMMUNOGLOBULIN-G FROM PATIENTS WITH PRIMARY MYXEDEMA - COMPARISON WITH ACTIVITIES OF THYROTROPIN-BINDING INHIBITOR IMMUNOGLOBULINS
    CHO, BY
    SHONG, YK
    LEE, HK
    KOH, CS
    MIN, HK
    [J]. ACTA ENDOCRINOLOGICA, 1989, 120 (01): : 99 - 106
  • [5] BINDING ASSAY FOR THYROTROPIN RECEPTOR AUTOANTIBODIES USING THE RECOMBINANT RECEPTOR PROTEIN
    COSTAGLIOLA, S
    SWILLENS, S
    NICCOLI, P
    DUMONT, JE
    VASSART, G
    LUDGATE, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06) : 1540 - 1544
  • [6] DEBRUIN TWA, 1988, J ENDOCRINOL INVEST, V11, P403
  • [7] THYROID GROWTH-BLOCKING ANTIBODIES IN PRIMARY MYXEDEMA
    DREXHAGE, HA
    BOTTAZZO, GF
    BITENSKY, L
    CHAYEN, J
    DONIACH, D
    [J]. NATURE, 1981, 289 (5798) : 594 - 596
  • [8] INHIBITION OF THYROTROPIN-INDUCED GROWTH OF RAT-THYROID CELLS, FRTL-5, BY IMMUNOGLOBULIN-G FROM PATIENTS WITH PRIMARY MYXEDEMA
    IIDA, Y
    KONISHI, J
    KASAGI, K
    MISAKI, T
    ARAI, K
    TOKUDA, Y
    TORIZUKA, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (01) : 124 - 130
  • [9] A NEW INVITRO ASSAY FOR HUMAN THYROID-STIMULATOR USING CULTURED THYROID-CELLS - EFFECT OF SODIUM-CHLORIDE ON ADENOSINE-3',5'-MONOPHOSPHATE INCREASE
    KASAGI, K
    KONISHI, J
    IIDA, Y
    IKEKUBO, K
    MORI, T
    KUMA, K
    TORIZUKA, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (01) : 108 - 114
  • [10] INHIBITION OF THYROTROPIN-INDUCED ADENOSINE 3'5'-MONOPHOSPHATE INCREASE BY IMMUNOGLOBULINS FROM PATIENTS WITH PRIMARY MYXEDEMA
    KONISHI, J
    IIDA, Y
    ENDO, K
    MISAKI, T
    NOHARA, Y
    MATSUURA, N
    MORI, T
    TORIZUKA, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (03) : 544 - 549